BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Reddy A, May E, Ehrinpreis M, Mutchnick M. Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C. World J Gastroenterol 2013; 19(48): 9328-9333 [PMID: 24409059 DOI: 10.3748/wjg.v19.i48.9328]
URL: https://www.wjgnet.com/1948-5182/full/v19/i48/9328.htm
Number Citing Articles
1
Minjie Wang, Yuting Wang, Xiaoshuang Feng, Ruijun Wang, Yanmei Wang, Hongmei Zeng, Jun Qi, Hong Zhao, Ni Li, Jianqiang Cai, Chunfeng Qu. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer CenterInternational Journal of Infectious Diseases 2017; 65: 15 doi: 10.1016/j.ijid.2017.09.003
2
S. Simona Jakab. Liver and Pancreatic Cancer Related to Hepatitis B ExposureJournal of Clinical Gastroenterology 2014; 48(8): 655 doi: 10.1097/MCG.0000000000000163
3
Nicola Coppola, Lorenzo Onorato, Caterina Sagnelli, Evangelista Sagnelli, Italo F. Angelillo. Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver diseaseMedicine 2016; 95(30): e4311 doi: 10.1097/MD.0000000000004311
4
Hanan Omar, Samaa Taha, Wafaa Hassan, Hamdy Omar. Occult hepatitis B infection: a hidden factor of poor response to intervention treatment of hepatocellular carcinoma in chronic hepatitis C patientsComparative Clinical Pathology 2018; 27(5): 1273 doi: 10.1007/s00580-018-2735-0
5
Kiyohiko Omichi, Junichi Shindoh, Satoshi Yamamoto, Yutaka Matsuyama, Nobuhisa Akamatsu, Junichi Arita, Junichi Kaneko, Yoshihiro Sakamoto, Kiyoshi Hasegawa, Norihiro Kokudo. Postoperative Outcomes for Patients with Non-B Non-C Hepatocellular Carcinoma: A Subgroup Analysis of Patients with a History of Hepatitis B InfectionAnnals of Surgical Oncology 2015; 22(S3): 1034 doi: 10.1245/s10434-015-4845-0
6
Erin E. Conners, Lakshmi Panagiotakopoulos, Megan G. Hofmeister, Philip R. Spradling, Liesl M. Hagan, Aaron M. Harris, Jessica S. Rogers-Brown, Carolyn Wester, Noele P. Nelson, Karina Rapposelli, Amy L. Sandul, Elisa Choi, Carla Coffin, Kristen Marks, David L. Thomas, Su H. Wang. Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023MMWR. Recommendations and Reports 2023; 72(1): 1 doi: 10.15585/mmwr.rr7201a1
7
Fei Wang, Jin-Lian Yang, Ke-ke Yu, Mei Xu, You-zhi Xu, Li Chen, Yan-min Lu, Hao-shu Fang, Xin-yi Wang, Zhong-qian Hu, Fei-fei Li, Lixin Kan, Jia Luo, Si-Ying Wang. Activation of the NF-κB pathway as a mechanism of alcohol enhanced progression and metastasis of human hepatocellular carcinomaMolecular Cancer 2015; 14(1) doi: 10.1186/s12943-014-0274-0
8
Nicola Coppola, Lorenzo Onorato, Mariantonietta Pisaturo, Margherita Macera, Caterina Sagnelli, Salvatore Martini, Evangelista Sagnelli. Role of occult hepatitis B virus infection in chronic hepatitis CWorld Journal of Gastroenterology 2015; 21(42): 11931-11940 doi: 10.3748/wjg.v21.i42.11931
9
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-AnalysisBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3417976
10
Jiarong Zhou, Nishta Krishnan, Yao Jiang, Ronnie H. Fang, Liangfang Zhang. Nanotechnology for virus treatmentNano Today 2021; 36: 101031 doi: 10.1016/j.nantod.2020.101031